Lincoln Pharmaceuticals Ltd (LINCOLN) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 294056, "name": "Lincoln Pharma.", "stock_name": "Lincoln Pharma.", "full_name": "Lincoln Pharmaceuticals Ltd", "name_url": "stocks-analysis/lincoln-pharma", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "604.40", "chg": -5.1, "chgp": "-0.84%", "dir": -1, "prev_price": "609.50", "mcapval": "1,205.00 Cr", "mcap": "Micro Cap", "scripcode": 531633, "symbol": "LINCOLN", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE405C01035", "curr_date": "Aug 07, 03:30 PM", "curr_time": "03:15 AM", "last_traded_at": "Aug 07, 03:30 PM IST", "bse_nse_vol": "23.7 k", "exc_status": "Active", "traded_date": "Aug 07, 2026", "traded_date_str": "2026 08 07", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/lincoln-pharma-294056-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Lincoln Pharmaceuticals Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/lincoln-pharmaceuticals-ltd-is-rated-hold-4142822", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/LincolnPharmace_mojoScore_4142822.png", "date": "2026-08-08 10:10:28", "description": "Lincoln Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 27 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "When is the next results date for Lincoln Pharmaceuticals Ltd?", "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-lincoln-pharmaceuticals-ltd-4142234", "imagepath": "", "date": "2026-08-07 23:18:27", "description": "The next results date for Lincoln Pharmaceuticals Ltd is scheduled for 13 August 2026...." }, { "title": "Lincoln Pharmaceuticals Ltd Technical Momentum Shifts Signal Mild Bullish Outlook", "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-ltd-technical-momentum-shifts-signal-mild-bullish-outlook-4134443", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/LincolnPharmace_technicaldot_4134443.png", "date": "2026-08-04 08:02:19", "description": "Lincoln Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. This change is underscored by a complex interplay of technical indicators, including MACD, RSI, moving averages, and Bollinger Bands, which collectively paint a nuanced picture of the stock’s near-term prospects within the Pharmaceuticals & Biotechnology sector." }, { "title": "Lincoln Pharmaceuticals Ltd’s Subtle Shift: -0.48% Weekly Dip Amid Mixed Technical Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-ltds-subtle-shift--048-weekly-dip-amid-mixed-technical-signals-4132153", "imagepath": "", "date": "2026-08-02 10:00:07", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>27 Jul:</strong> MarketsMOJO upgrades Lincoln Pharmaceuticals Ltd to Hold on technical and valuation improvements</p>\n <p><strong>31 Jul:</strong> Technical momentum shifts to sideways trend amid mixed indicator signals</p>\n <p><strong>31 Jul:</strong> Week closes at Rs.579.10, down 0.48% despite Sensex gains</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.581.90</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.579.10</div><div class=\"stat-chang..." }, { "title": "Lincoln Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicator Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4129431", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/LincolnPharmace_technicaldot_4129431.png", "date": "2026-07-31 08:00:37", "description": "Lincoln Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. Despite a recent downgrade in daily price performance, the stock’s monthly and weekly technical indicators present a complex picture, reflecting both bullish and bearish signals that investors should carefully analyse." }, { "title": "Lincoln Pharmaceuticals Ltd Upgraded to Hold on Technical and Valuation Improvements", "link": "https://www.marketsmojo.com/news/stock-recommendation/lincoln-pharmaceuticals-ltd-upgraded-to-hold-on-technical-and-valuation-improvements-4123554", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/LincolnPharmace_mojoScore_4123554.png", "date": "2026-07-28 08:11:27", "description": "Lincoln Pharmaceuticals Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a nuanced improvement across technical indicators, valuation metrics, and financial trends despite some lingering challenges. The micro-cap pharmaceutical company’s recent performance and outlook have prompted analysts to revise their stance, signalling cautious optimism for investors." }, { "title": "Lincoln Pharmaceuticals Falls 2.19%: 3 Key Factors Driving the Week’s Decline", "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-falls-219-3-key-factors-driving-the-weeks-decline-4121422", "imagepath": "", "date": "2026-07-26 15:00:05", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>20 Jul:</strong> Stock opens at ₹598.65, modest gain despite flat Sensex</p>\n <p><strong>22 Jul:</strong> Sharp decline to ₹579.00 amid technical and financial concerns</p>\n <p><strong>23 Jul:</strong> Downgrade to Sell rating announced; technical momentum shifts</p>\n <p><strong>24 Jul:</strong> Mild recovery to ₹581.90 with mixed technical signals</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.594.95</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><d..." }, { "title": "Lincoln Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicator Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4118495", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/LincolnPharmace_technicaldot_4118495.png", "date": "2026-07-24 08:00:54", "description": "Lincoln Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. Despite this positive directional change, a detailed analysis of key technical indicators such as MACD, RSI, Bollinger Bands, and moving averages reveals a complex picture, with mixed signals that warrant cautious interpretation by investors." }, { "title": "Lincoln Pharmaceuticals Downgraded to Sell Amid Technical and Financial Concerns", "link": "https://www.marketsmojo.com/news/stock-recommendation/lincoln-pharmaceuticals-downgraded-to-sell-amid-technical-and-financial-concerns-4117168", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/LincolnPharmace_mojoScore_4117168.png", "date": "2026-07-23 08:05:48", "description": "Lincoln Pharmaceuticals Ltd has been downgraded from a Hold to a Sell rating by MarketsMOJO as of 22 Jul 2026, reflecting a reassessment of its quality, valuation, financial trend, and technical outlook. Despite some long-term return strengths, the company faces challenges in growth momentum and technical indicators, prompting a more cautious stance from investors." } ], "total": 1005, "sid": "294056", "stock_news_url": "https://www.marketsmojo.com/news/lincoln-pharmaceuticals-294056" }, "announcements": [ { "caption": "Board Meeting Intimation for Board Meeting Intimation For Consideration And Approving The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended June 30 2026.", "datetime": "06-Aug-2026", "details": "Lincoln Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 inter alia to consider and approve Lincoln Pharmaceuticals Ltd has Informed BSE that the meeting of the Board of Directors of the Company is Scheduled on 13/08/2026 Inter alia to consider and approve Unaudited standalone and consolidated financial results of the Company for the quarter ended on June 30 2026.", "source": "BSE" }, { "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018", "datetime": "06-Jul-2026", "details": "Pursuant to provision of Regulation 74(5) of SEBI (Depository and Participants) Regulation 2018 we hereby submit the confirmation certificate received from MUFG Intime India Private Limited Registrar and Share Transfer Agent (RTA) for the Quarter ended June 30 2026.", "source": "BSE" }, { "caption": "Closure of Trading Window", "datetime": "24-Jun-2026", "details": "Intimation of Trading Window Closure for the Quarter ended June 30 2026.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "", "data": [ { "title": "BOARD MEETING", "txt": "13 Aug 2026" } ] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Lincoln Pharmaceuticals Ltd has declared <strong>18%</strong> dividend, ex-date: 12 Sep 25", "dt": "2025-09-12", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "", "data": [ { "txt": "Lincoln Pharmaceuticals Ltd has announced <strong>10:2</strong> stock split, ex-date: 19 Mar 09", "dt": "2009-03-19", "middle_text": "Split" } ] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

27 Jul: MarketsMOJO upgrades Lincoln Pharmaceuticals Ltd to Hold on technical and valuation improvements

31 Jul: Technical momentum shifts to sideways trend amid mixed indicator signals

31 Jul: Week closes at Rs.579.10, down 0.48% despite Sensex gains

Read full news article

Lincoln Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-07-31 08:00:37

Lincoln Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. Despite a recent downgrade in daily price performance, the stock’s monthly and weekly technical indicators present a complex picture, reflecting both bullish and bearish signals that investors should carefully analyse.

Read full news article

Lincoln Pharmaceuticals Ltd Upgraded to Hold on Technical and Valuation Improvements

2026-07-28 08:11:27

Lincoln Pharmaceuticals Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a nuanced improvement across technical indicators, valuation metrics, and financial trends despite some lingering challenges. The micro-cap pharmaceutical company’s recent performance and outlook have prompted analysts to revise their stance, signalling cautious optimism for investors.

Read full news article

Lincoln Pharmaceuticals Falls 2.19%: 3 Key Factors Driving the Week’s Decline

2026-07-26 15:00:05

Key Events This Week

20 Jul: Stock opens at ₹598.65, modest gain despite flat Sensex

22 Jul: Sharp decline to ₹579.00 amid technical and financial concerns

23 Jul: Downgrade to Sell rating announced; technical momentum shifts

24 Jul: Mild recovery to ₹581.90 with mixed technical signals

Week Open

Rs.594.95

Week Close

Read full news article

Lincoln Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-07-24 08:00:54

Lincoln Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. Despite this positive directional change, a detailed analysis of key technical indicators such as MACD, RSI, Bollinger Bands, and moving averages reveals a complex picture, with mixed signals that warrant cautious interpretation by investors.

Read full news article

Lincoln Pharmaceuticals Downgraded to Sell Amid Technical and Financial Concerns

2026-07-23 08:05:48

Lincoln Pharmaceuticals Ltd has been downgraded from a Hold to a Sell rating by MarketsMOJO as of 22 Jul 2026, reflecting a reassessment of its quality, valuation, financial trend, and technical outlook. Despite some long-term return strengths, the company faces challenges in growth momentum and technical indicators, prompting a more cautious stance from investors.

Read full news article

View All News